Kinex Phrarmaceuticals (Buffalo) Receives Therapeutic Discovery Grant (12/8/2010)

Kinex Pharmaceuticals develops and commercializes therapies for cancer and immunomodulatory diseases. The company’s technology is based on work performed by University at Buffalo Chemistry Professor David Hangauer, who serves as Senior Vice President, Research and Development.

From the company’s press release:
Kinex Pharmaceuticals has been awarded a grant from the Qualifying Therapeutic Discovery Project tax credit program which is provided under new section 48D of the Internal Revenue Code (IRC) enacted as part of the Patient Protection and Affordable Care Act of 2010. read full press release


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: